Be one of our founding early access partners.
We’re selecting a small number of founding partners to bring TissueTinker’s system onto their own bench, and to help shape where it goes next.
What you get
- Early access: to the bioprinter, the model library, and our organ-specific bioinks.
- Your own tumor models, in-house, in weeks: run the conditions you care about, on the cells you already work with.
- Direct work with our team: we’re in this with you, not handing you a box.
- A hand in the roadmap: founding partners influence the models and organ types we build next.
How early access works
- Tell us about your work. What are you trying to study, and with which cells?
- We scope it together. We match it to the right bioink and geometry, and agree what success looks like.
- We help review the results, and you decide where to take it next.
Who it’s for
Oncology biotechs, pharma teams, and academic groups working on solid tumors, especially where tissue context and the tumor–stroma relationship matter. Organ models available today include head and neck, colorectal, gastroesophageal, and healthy liver, with more in development.
The evidence
We’d rather show you the science than a list of logos. Our technical whitepaper lays out how the system performs: invasion fidelity, human-like drug response, and stroma that behaves like real tissue.
Apply for early access
Tell us a bit about what you’d like to model.